Published: 2018-08-23

Comparative study about knowledge, attitude and practice study of fixed dose combination among junior residents and interns of a tertiary care hospital

Rupa Arun Korde, Radhika M. S., Priya Gandigawad, Ravi Sori, Amruth .


Background: Fixed Dose Combinations (FDCs) are defined by the World Health Organization (WHO) as combination of two or more active ingredients in a fixed ratio of doses. According to the FDA, “two or more drugs may be combined in a single dose when each component makes a contribution to the claimed effects, and the dosage of each component (i.e., amount, frequency, and duration) is such that the combination is safe and effective for significant patient population requiring such concurrent therapy. However, certain disadvantages like incompatible pharmacokinetics, inflexible dose ratio, increased toxicity and cost, contraindication of one component of the FDC decreased their utility. Adverse effect of any one component also limits their use. The aim of the study is to compare and evaluate the knowledge, attitude and practices about prescribing fixed dose combinations among junior resident doctors (JRs) and interns (INTs) at SDM College of Medical Sciences and Hospital Dharwad.

Methods: A cross-sectional study was carried out in 134 doctors using pre-validated 10 item questionnaire with details of participant’s information followed by questions regarding knowledge, attitude and prescribing practice of fixed dose combinations was used as a tool, administrated to all the resident doctors and the collected data was analysed.

Results: Our study revealed that knowledge about FDCs was lacking in JRs and INTs. They were not able to point out the actual advantages and disadvantages of FDCs. Knowledge about rational/irrational, banned FDCs and availability of WHO EML was also lacking.

Conclusions: There is need to improve knowledge about rationality, essential medicine list, usage and banned FDCs in undergraduate medical students to promote the rational use of drugs.


Adverse effect, Essential medicine list, FDCs, WHO

Full Text:



WHO Expert Committee on Specifications for Pharmaceutical Preparations: thirty-ninth report. (WHO technical report series; 929); 2005.

Sreedhar D, Subramanian G, Udupa N. Combination drugs: are they rational? Curr Sci. 2006;91:406.

World Health Organization. The use of essential drugs. WHO Technical Report Series 825. Geneva: World Health Organization; 1992.

Fixed dose combinations approved by DCGI (i) since 1961 till November 2014. Available at: (1) _2013. Pdf (Accessed 18 May 2014).

WHO Model List of Essential Medicines. Available at: publications/essentialmedicines/18th_EML_Final_web_8Jul13.pdf (accessed 28 December 2014).

National List of Essential Medicines of India; 2011. Available at: medicinedocs/documents/s18693en/s18693en.pdf (accessed 28 December 2014).

Kataria BC, Bhavsar VH, Donga BN. Contemplation on approved drugs in India from 1999 through 2011. Asian J Pharm Clin Res. 2012;5(3):25-9.

Devi M, Sriram S, Rajalingam B, Anthraper AR, Varghese RS, Phani V. Evaluation of the rationality of fixed dose combinations of cardiovascular drugs in a multispecialty tertiary care hospital in Coimbatore, TN, India. Hygeia JD. 2012;4(1):51-8.

Badran IG. Knowledge, attitude and practice the three pillars of excellence and wisdom: A place in the medical profession. Eastern Mediterranean Hea J. 1995;1:8‑16.

Sarkar C, Das B. Prescribing trends of fixed dose combinations in a tertiary care hospital in Nepal. J Inst Med. 2000;22:53‑8.

Shewade D, Pradhan S. Auditing of prescriptions in a government teaching hospital and four retail medical stores in Pondicherry. Indian J Pharmacol. 1998;30:408‑10.

Sreedhar D, Subramanian G, Udupa. N. Combination drugs: Are they rational? Curr Sci. 2006;91:24‑5.